STAA Q3 2018 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q3 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$32M+35.3% YoY

Gross Profit

$24M75.1% margin

Operating Income

$2M5.0% margin

Net Income

$1M4.6% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-6.3%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$163M

Total Liabilities

$34M

Stockholders' Equity

$129M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$23M	+35.3%
Gross Profit	$24M	$17M	+41.6%
Operating Income	$2M	$1M	+51.8%
Net Income	$1M	$1M	+24.4%

Revenue Segments

Implantable Collamer Lenses

$26M83%

Intraocular Lenses

$4M12%

Other Surgical Products

$2M5%

Geographic Segments

CHINA

$13M42%

Other Countries

$12M39%

JAPAN

$6M19%